All Phenotypes Ppp1r3c<tm1Ars> MGI Mouse

growth/size/body

increased heart weight ( J:83297 )

• 25% increase in heart weight and heart/body weight ratio is seen in aged mutants

adipose tissue

decreased adipose tissue glycogen level ( J:83297 )

• in a non-fasting state, mutants show a reduction in glycogen stores in adipose tissue (54% less)

homeostasis/metabolism

increased circulating leptin level ( J:83297 )

• fasting serum leptin levels are elevated in older mutants

increased circulating triglyceride level ( J:83297 )

• serum levels of fasting, but not non-fasting, triglycerides are increased by about 32% at 18 months of age

abnormal glucose homeostasis ( J:83297 )

• 180% increase in glucose transport into the epididymal adipose depot

increased circulating insulin level ( J:83297 )

• develop hyperinsulinemia with age; fasting serum insulin levels are elevated 2-fold at 1-2 months of age and 3-fold at 10 months of age

impaired glucose tolerance ( J:83297 )

• develop progressive glucose intolerance with age

abnormal glycogen homeostasis ( J:83297 )

• insulin-stimulated glycogen synthesis is reduced

decreased glycogen level ( J:83297 )

• in a non-fasting state, mutants show a reduction in glycogen stores in adipose tissue (54% less), liver (42% less), heart (48% less), and skeletal muscle (26% less)

• in a fasted state, mutants show a 25% reduction in hepatic and heart glycogen

decreased adipose tissue glycogen level ( J:83297 )

• in a non-fasting state, mutants show a reduction in glycogen stores in adipose tissue (54% less)

decreased cardiac muscle glycogen level ( J:83297 )

• in a non-fasting state, mutants show a reduction in glycogen stores in heart (48% less)

• in a fasted state, mutants show a 25% reduction in heart glycogen

decreased liver glycogen level ( J:83297 )

• in a non-fasting state, mutants show a reduction in glycogen stores in liver (42% less)

• in a fasted state, mutants show a 25% reduction in hepatic glycogen

decreased skeletal muscle glycogen level ( J:83297 )

• in a non-fasting state, mutants show a reduction in glycogen stores in skeletal muscle (26% less)

insulin resistance ( J:83297 )

• develop insulin resistance with age

increased skeletal muscle triglyceride level ( J:83297 )

• skeletal muscle of 18 month old mutants shows 30% increase in triglyceride content

abnormal enzyme/coenzyme activity ( J:83297 )

• decrease in glycogen synthase activity in 1-2 month old mutants

liver/biliary system

decreased liver glycogen level ( J:83297 )

• in a non-fasting state, mutants show a reduction in glycogen stores in liver (42% less)

• in a fasted state, mutants show a 25% reduction in hepatic glycogen

muscle

decreased cardiac muscle glycogen level ( J:83297 )

• in a non-fasting state, mutants show a reduction in glycogen stores in heart (48% less)

• in a fasted state, mutants show a 25% reduction in heart glycogen

decreased skeletal muscle cell glucose uptake ( J:83297 )

• glucose uptake by white fiber quadriceps muscle is reduced by 35% in 3-4 month old mutants

• however, uptake into mixed fiber gastrocnemius muscle is not altered

decreased skeletal muscle glycogen level ( J:83297 )

• in a non-fasting state, mutants show a reduction in glycogen stores in skeletal muscle (26% less)

increased skeletal muscle triglyceride level ( J:83297 )

• skeletal muscle of 18 month old mutants shows 30% increase in triglyceride content

cardiovascular system

decreased cardiac muscle glycogen level ( J:83297 )

• in a non-fasting state, mutants show a reduction in glycogen stores in heart (48% less)

• in a fasted state, mutants show a 25% reduction in heart glycogen

increased heart weight ( J:83297 )

• 25% increase in heart weight and heart/body weight ratio is seen in aged mutants

cellular

decreased skeletal muscle cell glucose uptake ( J:83297 )

• glucose uptake by white fiber quadriceps muscle is reduced by 35% in 3-4 month old mutants

• however, uptake into mixed fiber gastrocnemius muscle is not altered

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
type 2 diabetes mellitus		DOID:9352	OMIM:125853 OMIM:601283 OMIM:601407 OMIM:603694 OMIM:608036	J:83297

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/10/2024 MGI 6.24